You have 9 free searches left this month | for more free features.

Giant Cell Tumors

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Solid Tumor Trial in Kanto Region (ONO-4538)

Completed
  • Malignant Solid Tumor
  • ONO-4538
  • Kanto Region, Kanto, Japan
    (unnamed)
Sep 15, 2020

Mitapivat in Subjects With Sickle Cell Disease

Enrolling by invitation
  • Sickle Cell Anemia
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

    Recruiting
    • Hemoglobinopathy (Disorder)
    • +2 more
    • Haploidentical Hematopoietic Cell Transplantation
    • Saint Petersburg, Florida
      Johns Hopkins All Children's Hospital
    Sep 13, 2022

    Glioblastoma Multiforme, Brain Tumors, Gastroesophageal Adenocarcinoma Trial in Lyon Cedex (68Ga-FF58)

    Recruiting
    • Glioblastoma Multiforme
    • +3 more
    • Lyon Cedex, France
      Novartis Investigative Site
    Aug 9, 2022

    Liver Cirrhosis Trial in Kharkov (Autologous BM MSC)

    Active, not recruiting
    • Liver Cirrhosis
    • Autologous BM MSC
    • Kharkov, Ukraine
      Institute of Bio-Stem Cell Rehabilitation
    May 16, 2022

    Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

    Recruiting
    • Immune Deficiency Disorders
    • +13 more
    • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
    • Saint Louis, Missouri
      Washington University
    Apr 25, 2022

    Skin Cancer, Mucosal Tumor of Oral Cavity, Soft Tissue Tumor Trial in Haifa (Radiation: Diffusing Alpha Radiation Emitters

    Recruiting
    • Skin Cancer
    • +2 more
    • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
    • Haifa, Israel
      RAMBAM Health Care Campus
    Feb 16, 2022

    Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 31, 2022

    Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,

    Not yet recruiting
    • Advanced Head and Neck Squamous Cell Carcinoma
    • +2 more
    • CyPep-1
    • Pembrolizumab 25 MG/ML [Keytruda]
    • Pittsburgh, Pennsylvania
    • +18 more
    Nov 21, 2022

    Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

    Not yet recruiting
    • Cancer
      • (no location specified)
      Feb 7, 2023

      Lymphoma Trial in Berne (Brentuximab Vedotin, BeEAM Regimen)

      Recruiting
      • Lymphoma
      • Brentuximab Vedotin
      • BeEAM Regimen
      • Berne, Switzerland
        Department for Medical Oncology University Hospital/Inselspital
      Feb 4, 2022

      Malignant Bone Tumors Trial in Boston (Radiation (Surgical Arm), Radiation (Non-surgical Arm), Malignant Tumor Surgery)

      Completed
      • Malignant Bone Tumors
      • Radiation (Surgical Arm)
      • +2 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Nov 8, 2021

      Anemia Severe Trial in Pittsburgh (HBOC-201)

      Available
      • Anemia Severe
      • HBOC-201
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Medical Center
      May 16, 2022

      Small-Cell Lung Cancer Trial in Worldwide (Durvalumab, AZD2811, Carboplatin)

      Active, not recruiting
      • Small-Cell Lung Cancer
      • Grand Rapids, Michigan
      • +11 more
      Apr 25, 2022

      Cognitive Impairment, Hematologic Tumors, Hematopoietic Cell Transplant Trial in Birmingham (Lumosity, Lumosity (waitlist

      Recruiting
      • Cognitive Impairment
      • +2 more
      • Lumosity
      • Lumosity (waitlist control)
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Apr 25, 2022

      Learn More About NTRK Gene Fusion Positive in Solid Tumor in

      Not yet recruiting
      • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
      • No Drug
      • Multiple Locations, Japan
        Many Locations
      Mar 20, 2023

      Locally Advanced or Metastatic Solid Tumors Trial in Groningen (MPDL3280A)

      Recruiting
      • Locally Advanced or Metastatic Solid Tumors
      • Groningen, Netherlands
        University Medical Center Groningen
      Feb 28, 2022

      PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark

      Recruiting
      • Anal Cancer
        • Aarhus, Denmark
        • +2 more
        Oct 5, 2022

        CD19+ and CD 22+ B-ALL Trial in Langfang (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells, Cyclophosphamide,Fludarabine)

        Recruiting
        • CD19+ and CD 22+ B-ALL
        • Langfang, Hebei, China
          Hebei Yanda Ludaopei Hospital
        Jan 25, 2022

        Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract Trial in United States (Renal Autologous Cell Therapy

        Recruiting
        • Chronic Kidney Disease
        • Congenital Anomalies of Kidney and Urinary Tract
        • Renal Autologous Cell Therapy (REACT®)
        • Meridian, Idaho
        • +5 more
        Mar 9, 2022

        Cancer Trial in Malvern East, Sydney, Wollongong (YH004)

        Recruiting
        • Cancer
        • Malvern East, Australia
        • +2 more
        Dec 7, 2021

        Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

        Recruiting
        • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
        • Frankfurt, Germany
          Department of Medicine, Hematology and Oncology, Goethe Universi
        Sep 24, 2023

        White Blood Cells Engulfing Red Blood Cells Trial in Brussel (No intervention, observational study)

        Recruiting
        • White Blood Cells Engulfing Red Blood Cells
        • No intervention, observational study
        • Brussel, Belgium
          UZ Brussel
        Jan 30, 2023

        BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)

        Recruiting
        • Renal Cancer Metastatic
        • Immunological and tumour characterization
        • Lyon, France
          Centre Leon Berard
        Mar 14, 2022